Journal ArticleDOI
Hs-CRP and all-cause, cardiovascular, and cancer mortality risk: A meta-analysis.
Yunwei Li,Xiaoming Zhong,Guanchang Cheng,Cui-Hua Zhao,Lei Zhang,Yan Hong,Qilin Wan,Ruili He,Zhizhong Wang +8 more
Reads0
Chats0
TLDR
Elevated hs-CRP levels can independently predict risk of all-cause, cardiovascular mortality in the general population, however, the gender differences in the predictive role of hs -CRP on cancer mortality should to be further investigated.About:
This article is published in Atherosclerosis.The article was published on 2017-04-01. It has received 239 citations till now. The article focuses on the topics: Standardized mortality ratio & Population.read more
Citations
More filters
Journal ArticleDOI
More than a feeling: A unified view of stress measurement for population science.
Elissa S. Epel,Alexandra D. Crosswell,Stefanie E. Mayer,Aric A. Prather,George M. Slavich,Eli Puterman,Wendy Berry Mendes +6 more
TL;DR: An integrative working model is articulated, highlighting how stressor exposures across the life course influence habitual responding and stress reactivity, and how health behaviors interact with stress, and a Stress Typology articulating timescales for stress measurement is offered.
Journal ArticleDOI
Rethinking IL-6 and CRP: Why they are more than inflammatory biomarkers, and why it matters.
TL;DR: It is argued that both IL-6 and CRP participate in somatic maintenance efforts; hence elevated levels indicate that an organism is investing in protection, preservation, and/or repair of somatic tissue.
Journal ArticleDOI
Research Progress on the Relationship between Atherosclerosis and Inflammation.
Yuhua Zhu,Xuemei Xian,Zhenzhen Wang,Yingchao Bi,Quangang Chen,Xufeng Han,Daoquan Tang,Renjin Chen +7 more
TL;DR: Atherosclerosis is a chronic inflammatory disease; unstable atherosclerotic plaque rupture, vascular stenosis, or occlusion caused by platelet aggregation and thrombosis lead to acute cardiovascular disease.
Journal ArticleDOI
Prevalence of low-grade inflammation in depression: a systematic review and meta-analysis of CRP levels
Emanuele F. Osimo,Emanuele F. Osimo,Emanuele F. Osimo,Luke James Baxter,Glyn Lewis,Peter B. Jones,Peter B. Jones,Gulam Khandaker,Gulam Khandaker +8 more
TL;DR: The findings suggest that inflammation could be relevant to a large number of patients with depression, and over half of patients show mildly elevated CRP levels.
Journal ArticleDOI
Efficacy and safety of bempedoic acid added to ezetimibe in statin-intolerant patients with hypercholesterolemia: A randomized, placebo-controlled study.
Christie M. Ballantyne,Maciej Banach,G.B. John Mancini,Norman E. Lepor,Jeffrey C. Hanselman,Xin Zhao,Lawrence A. Leiter +6 more
TL;DR: Bempedoic acid may provide an oral therapeutic option complementary to ezetimibe in statin intolerant patients who require additional LDL-C lowering.
References
More filters
Journal ArticleDOI
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
TL;DR: Moher et al. as mentioned in this paper introduce PRISMA, an update of the QUOROM guidelines for reporting systematic reviews and meta-analyses, which is used in this paper.
Journal Article
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
TL;DR: The QUOROM Statement (QUality Of Reporting Of Meta-analyses) as mentioned in this paper was developed to address the suboptimal reporting of systematic reviews and meta-analysis of randomized controlled trials.
Journal ArticleDOI
Measuring inconsistency in meta-analyses
TL;DR: A new quantity is developed, I 2, which the authors believe gives a better measure of the consistency between trials in a meta-analysis, which is susceptible to the number of trials included in the meta- analysis.
Journal ArticleDOI
Bias in meta-analysis detected by a simple, graphical test
TL;DR: Funnel plots, plots of the trials' effect estimates against sample size, are skewed and asymmetrical in the presence of publication bias and other biases Funnel plot asymmetry, measured by regression analysis, predicts discordance of results when meta-analyses are compared with single large trials.
Journal ArticleDOI
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
TL;DR: PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) is introduced, an update of the QUOROM guidelines for reporting systematic reviews and meta-analyses.
Related Papers (5)
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
Paul M. Ridker,Brendan M. Everett,Tom Thuren,Jean G. MacFadyen,William Chang,Christie M. Ballantyne,Francisco H. Fonseca,Jose C. Nicolau,Wolfgang Koenig,Stefan D. Anker,John J.P. Kastelein,Jan H. Cornel,Prem Pais,Daniel Pella,Jacques Genest,Renata Cifkova,Alberto J. Lorenzatti,Tamás Forster,Zhanna Kobalava,Luminita Vida-Simiti,Marcus Flather,Hiroaki Shimokawa,Hisao Ogawa,Mikael Dellborg,Paulo Roberto Ferreira Rossi,Roland P.T. Troquay,Peter Libby,Robert J. Glynn +27 more